https://www.indianpharmapost.com/fda-approves-bayers-lynkuet-as-first-hormone-free-therapy-for-menopausal-hot-flashes-180872025-10-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/askbios-gene-therapy-shows-promising-12-month-results-for-heart-failure-180882025-10-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/elixion-biotech-takes-quantum-informed-rd-route-for-next-gen-precision-medicines-180892025-10-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-grants-fast-track-status-to-heidelberg-pharmas-amanitin-based-adc-candidate-for-multiple-myeloma-180902025-10-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/mira-pharmaceuticals-advances-oral-ketamir-2-into-phase-1-mad-study-for-chemotherapy-induced-neuropathic-pain-180912025-10-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/medherant-announces-positive-phase-1-results-of-clinical-trial-of-testosterone-patch-for-women-180922025-10-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/orion-secures-license-to-abzenas-next-generation-cancer-antibody-180932025-10-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/novartis-completes-acquisition-of-tourmaline-bio-180942025-10-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-approves-alembics-ticagrelor-tablets-60-mg-180952025-10-29T00:00:00+05:30always0.9